In 2025, Intco Medical Technology completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Intco Medical Technology has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022-2019 |
|---|---|---|---|---|
Total Scope 1 | 1,529,400a | 1,366,700a | 1,409,300a | |
Total Scope 2 | ||||
Unspecified Calculation Method | 343,100a | 346,300a | 290,800a | |
Total Scope 3 | N/A | N/A | N/A | |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 1,078.7104a | 1,047.3571a | 1,447.6505a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2025, the total operational greenhouse gas (GHG) emissions of Intco Medical Technology amounted to 1,872,500 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Intco Medical Technology increased by 9.31%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
In 2025, the total Scope 1 emissions of Intco Medical Technology were 1,529,400 metric tons of CO₂ equivalent (tCO₂e).a
Since 2023, Intco Medical Technology's Scope 1 emissions have increased by 8.52%, reflecting a rising long-term trend in Scope 1 emissions over time.a
Compared to the previous year (2024), Intco Medical Technology's Scope 1 emissions increased by 11.9%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a
In 2025, Intco Medical Technology reported Scope 2 greenhouse gas (GHG) emissions of 343,100 tCO₂e without specifying the calculation method.a
Since 2023, Intco Medical Technology's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 17.98%, reflecting a rising long-term trend in Scope 2 emissions over time.a
Compared to the previous year (2024), Intco Medical Technology's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Intco Medical Technology's emissions have plateaued with no significant change in its energy consumption footprint.a
In 2025, Intco Medical Technology reported its Scope 2 emissions using an unspecified methodology.a
In 2025, Intco Medical Technology reported Scope 1 greenhouse gas (GHG) emissions of 1,529,400 tCO₂e and total revenues of USD 1,418 millions. This translates into an emissions intensity of 1,078.71 tCO₂e per millions USD.a
In 2025, Intco Medical Technology reported a Scope 1 emissions intensity of 1,078.71 tCO₂e per millions USD. Compared to the peer group median of 4.53, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
In 2025, Intco Medical Technology ranked 25 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places Intco Medical Technology among the least efficient performers, with one of the highest emissions intensities in its sector.a